CLARIFICATION – 6/3/26
An earlier version of this article stated that the Practical Implications section included Controlled Substances Act registration, storage, handling, and loss-reporting. The clarification reflects implications for applicable clinical settings handling controlled substances. ARNP responsibility for opioid prescribing or dispensing is distinct from Med Spa operator responsibility for medication handling and management. The article has been updated accordingly.
An April 2026 Iowa Board of Nursing settlement suspended the nursing license of a former Ames health spa ARNP for at least 12 months. The agreement addressed alleged violations in documentation, drug administration, controlled substances, and opioid PMP review.
Nursing Board Settlement Addresses Former Medical Director Misconduct Allegations
On April 23, 2026, the Iowa Board of Nursing suspended former Live Hydration Spa ARNP Antoinette Thompson’s nursing license for at least 12 months under a settlement agreement. The agreement addressed alleged violations in patient documentation, controlled-substance prescribing, drug administration, and opioid Prescription Monitoring Program (PMP) review. For Med Spa operators, the action highlights compliance exposure around provider roles, prescription authority, and medication handling.
Charges, Suspension, and Timeline in Former Medical Director Settlement
The Iowa Board of Nursing’s April 2026 settlement states that Thompson was a co-owner and provider of Live Hydration Spa in Ames from March 2023 to September 2024. In the agreement, the board alleged that, during that period, she prescribed controlled substances without corresponding clinical documentation and without reviewing the opioid PMP as required. The agreement also alleged that she ordered non-patient-specific “office stock” medications that were later used for patients for whom the medications were not prescribed.
On April 10, 2025, the Iowa Board of Nursing found probable cause to file charges against Thompson. The board’s notice charged her with violations involving patient assessment and documentation, drug prescribing and administration, controlled substances, nursing practice standards, and opioid PMP review. Before the final settlement, Thompson agreed to a stipulated order prohibiting her from practicing as an ARNP or using her Controlled Substances Act (CSA) numbers pending further board action. This order was approved by the Iowa Board of Nursing and the Iowa Board of Pharmacy in October 2025.
Before seeking reinstatement, the agreement requires Thompson to complete 15 hours of board-approved education, including coursework on medical documentation, recordkeeping, proper prescribing, medical ethics, controlled-substance prescribing, patient assessment, and health care fraud, waste, and abuse. If the Iowa Board of Nursing approves reinstatement, her nursing license will be placed on probation for two years, and she must establish a monitoring program with the board.
KCRG reported on May 18, 2026, that the Iowa Board of Pharmacy separately charged Thompson with violations involving controlled-substance registration, storage, and handling. The reported pharmacy allegations included using the wrong CSA registration, using a business-specific CSA registration after leaving that business, failing to maintain separate registrations for each business using controlled substances, and failing to immediately report theft or significant losses.
DISCOVER YOUR MED SPA’S GROWTH POTENTIAL
How much time and revenue could you unlock by outsourcing your GFEs?
Use our GFE Calculator to find out in under 5 minutes. It’s quick, easy, and tailored to your Med Spa.
Iowa Nursing Board Records and KCRG Reporting Document the Case
According to the Iowa Board of Nursing’s settlement agreement and final order, Thompson signed the agreement on April 22, 2026, and the board accepted it on April 23, 2026, suspending her Iowa nursing license for a minimum of 12 months. KCRG also reported on May 18, 2026, that court records identified Thompson as the former medical director and nurse for Live Hydration Spa in Ames.
Nursing and Pharmacy Board Actions Highlight Medication Oversight Risks
The Iowa board actions involved both provider conduct and controlled-substance oversight. The nursing-board record addressed Thompson’s conduct as an ARNP, including patient documentation, prescribing, medication administration, and PMP review. The pharmacy-board matter, as reported by KCRG, addressed a separate set of allegations involving CSA registration, drug storage, handling, and loss reporting.
Under Iowa Administrative Code rule 481—621.6, an ARNP may prescribe, administer, or dispense prescription drugs, devices, and controlled substances when acting within the ARNP’s role and population focus. The rule also requires the health record to document a recognized indication for controlled-substance use and requires review of the patient’s health history, including substance-abuse risk information or a documented rationale for not doing so.
The pharmacy board allegations add a location-specific compliance layer. In controlled-substance matters, oversight may involve whether the correct CSA registration was used for the correct business, whether drugs were stored and accounted for properly, and whether theft or significant losses were reported as required.
For Med Spa operators, the Iowa matter is most relevant to businesses in which a single licensed provider serves multiple roles, including owner, prescriber, injector, IV therapy provider, or medical director. Similar overlap appeared in April 2026, reporting on Texas IV therapy charges tied to Luxe Med Spa and Jenifer’s Law, where delegation and supervision were central after a reported July 2023 IV therapy death. A Florida vitamin injection business case also involved credentialing and supervision allegations after a reported injection-related injury.
Medication Oversight Implications for Iowa APRNs and Med Spa Operators
- Verify clinical records reflect the required patient evaluation, medication order, and treatment performed by the ARNP or treating provider.
- Document ARNP responsibility for Prescription Monitoring Program review when opioids are prescribed or dispensed in an applicable clinical setting.
- Maintain patient-specific medication records when ordering, storing, or administering medications in a Med Spa setting.
- Confirm the ARNP Controlled Substances Act registration applies to the clinical setting, business location, and controlled-substance activity involved.
- Define operating responsibilities for medication storage, inventory, loss reporting, clinical documentation, and provider oversight.
- Separate patient care, prescribing, medication access, and business functions when responsibilities overlap.
What to Watch Next
A civil trial involving Thompson and Live Hydration is scheduled for Dec. 15, 2026, according to KCRG. Further public filings or board records may add context for Med Spa operators using ARNP-led treatment models, prescription medications, IV therapy, or controlled substances in Med Spa settings.
About Spakinect
Spakinect provides compliance infrastructure and telehealth-supported supervision solutions for medical aesthetic practices. For additional information, see our website.
Image Attribution: “Des Moines Municipal Building – eastern front” by James Steakley, via Wikimedia Commons, licensed under CC BY-SA 4.0.
